Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients
Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Embase, Medline and Pubmed were searc...
Saved in:
| Published in | International journal of cardiology Vol. 371; pp. 432 - 440 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
15.01.2023
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0167-5273 1874-1754 1874-1754 |
| DOI | 10.1016/j.ijcard.2022.09.062 |
Cover
| Abstract | Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients.
Embase, Medline and Pubmed were searched for studies comparing SMuRF-less and SMuRF patients with first presentation of ACS. We conducted single-arm analyses to determine the proportion of SMuRF-less patients in the ACS cohort, and compared the clinical presentation and outcomes of these patients.
Of 1,285,722 patients from 15 studies, 11.56% were SMuRF-less. A total of 7.44% of non-ST-segment-elevation ACS patients and 12.87% of ST-segment-elevation myocardial infarction (STEMI) patients were SMuRF-less. The proportion of SMuRF-less patients presenting with STEMI (60.71%) tended to be higher than those with SMuRFs (49.21%). Despite lower body mass index and fewer comorbidities such as chronic kidney disease, peripheral arterial disease, stroke and heart failure, SMuRF-less patients had increased in-hospital mortality (RR:1.57, 95%CI:1.38 to 1.80) and cardiogenic shock (RR:1.39, 95%CI:1.18 to 1.65), but lower risk of heart failure (RR:0.91, 95%CI:0.83 to 0.99). On discharge, SMuRF-less patients were prescribed less statins (RR:0.93, 95%CI:0.91 to 0.95), beta-blockers (RR:0.94, 95%CI:0.92 to 0.96), P2Y12 inhibitors (RR: 0.98, 95%CI: 0.96 to 0.99), and angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (RR:0.92, 95%CI:0.75 to 0.91).
In this study level meta-analysis, SMuRF-less ACS patients demonstrate higher mortality compared with patients with at least one traditional atherosclerotic risk factor. Underuse of guideline-directed medical therapy amongst SMuRF-less patients is concerning. Unraveling novel risk factors amongst SMuRF-less individuals is the next important step.
Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes mellitus, hyperlipidemia, hypertension, and smoking, are often used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Of 1,285,722 ACS patients, 11.56% were SMuRF-less. Despite lower body mass index and fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock. However, despite worse outcomes, SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge.
Central Illustration. The Overall Proportion, Clinical Presentation, and Outcomes of SMuRF-less Patients with ACS. [Display omitted]
•Standard modifiable risk factors (SMuRF - diabetes, hyperlipidemia, hypertension, smoking) are used for stratification in ACS.•Recent studies have showed an increasing proportion of SMuRF-less ACS patients.•Of 1,285,722 ACS patients, 11.56% were SMuRF-less.•Despite fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock.•SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge. |
|---|---|
| AbstractList | Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients.
Embase, Medline and Pubmed were searched for studies comparing SMuRF-less and SMuRF patients with first presentation of ACS. We conducted single-arm analyses to determine the proportion of SMuRF-less patients in the ACS cohort, and compared the clinical presentation and outcomes of these patients.
Of 1,285,722 patients from 15 studies, 11.56% were SMuRF-less. A total of 7.44% of non-ST-segment-elevation ACS patients and 12.87% of ST-segment-elevation myocardial infarction (STEMI) patients were SMuRF-less. The proportion of SMuRF-less patients presenting with STEMI (60.71%) tended to be higher than those with SMuRFs (49.21%). Despite lower body mass index and fewer comorbidities such as chronic kidney disease, peripheral arterial disease, stroke and heart failure, SMuRF-less patients had increased in-hospital mortality (RR:1.57, 95%CI:1.38 to 1.80) and cardiogenic shock (RR:1.39, 95%CI:1.18 to 1.65), but lower risk of heart failure (RR:0.91, 95%CI:0.83 to 0.99). On discharge, SMuRF-less patients were prescribed less statins (RR:0.93, 95%CI:0.91 to 0.95), beta-blockers (RR:0.94, 95%CI:0.92 to 0.96), P2Y12 inhibitors (RR: 0.98, 95%CI: 0.96 to 0.99), and angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (RR:0.92, 95%CI:0.75 to 0.91).
In this study level meta-analysis, SMuRF-less ACS patients demonstrate higher mortality compared with patients with at least one traditional atherosclerotic risk factor. Underuse of guideline-directed medical therapy amongst SMuRF-less patients is concerning. Unraveling novel risk factors amongst SMuRF-less individuals is the next important step.
Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes mellitus, hyperlipidemia, hypertension, and smoking, are often used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Of 1,285,722 ACS patients, 11.56% were SMuRF-less. Despite lower body mass index and fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock. However, despite worse outcomes, SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge.
Central Illustration. The Overall Proportion, Clinical Presentation, and Outcomes of SMuRF-less Patients with ACS. [Display omitted]
•Standard modifiable risk factors (SMuRF - diabetes, hyperlipidemia, hypertension, smoking) are used for stratification in ACS.•Recent studies have showed an increasing proportion of SMuRF-less ACS patients.•Of 1,285,722 ACS patients, 11.56% were SMuRF-less.•Despite fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock.•SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge. Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients.BACKGROUNDStandard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients.Embase, Medline and Pubmed were searched for studies comparing SMuRF-less and SMuRF patients with first presentation of ACS. We conducted single-arm analyses to determine the proportion of SMuRF-less patients in the ACS cohort, and compared the clinical presentation and outcomes of these patients.METHODSEmbase, Medline and Pubmed were searched for studies comparing SMuRF-less and SMuRF patients with first presentation of ACS. We conducted single-arm analyses to determine the proportion of SMuRF-less patients in the ACS cohort, and compared the clinical presentation and outcomes of these patients.Of 1,285,722 patients from 15 studies, 11.56% were SMuRF-less. A total of 7.44% of non-ST-segment-elevation ACS patients and 12.87% of ST-segment-elevation myocardial infarction (STEMI) patients were SMuRF-less. The proportion of SMuRF-less patients presenting with STEMI (60.71%) tended to be higher than those with SMuRFs (49.21%). Despite lower body mass index and fewer comorbidities such as chronic kidney disease, peripheral arterial disease, stroke and heart failure, SMuRF-less patients had increased in-hospital mortality (RR:1.57, 95%CI:1.38 to 1.80) and cardiogenic shock (RR:1.39, 95%CI:1.18 to 1.65), but lower risk of heart failure (RR:0.91, 95%CI:0.83 to 0.99). On discharge, SMuRF-less patients were prescribed less statins (RR:0.93, 95%CI:0.91 to 0.95), beta-blockers (RR:0.94, 95%CI:0.92 to 0.96), P2Y12 inhibitors (RR: 0.98, 95%CI: 0.96 to 0.99), and angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (RR:0.92, 95%CI:0.75 to 0.91).RESULTSOf 1,285,722 patients from 15 studies, 11.56% were SMuRF-less. A total of 7.44% of non-ST-segment-elevation ACS patients and 12.87% of ST-segment-elevation myocardial infarction (STEMI) patients were SMuRF-less. The proportion of SMuRF-less patients presenting with STEMI (60.71%) tended to be higher than those with SMuRFs (49.21%). Despite lower body mass index and fewer comorbidities such as chronic kidney disease, peripheral arterial disease, stroke and heart failure, SMuRF-less patients had increased in-hospital mortality (RR:1.57, 95%CI:1.38 to 1.80) and cardiogenic shock (RR:1.39, 95%CI:1.18 to 1.65), but lower risk of heart failure (RR:0.91, 95%CI:0.83 to 0.99). On discharge, SMuRF-less patients were prescribed less statins (RR:0.93, 95%CI:0.91 to 0.95), beta-blockers (RR:0.94, 95%CI:0.92 to 0.96), P2Y12 inhibitors (RR: 0.98, 95%CI: 0.96 to 0.99), and angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (RR:0.92, 95%CI:0.75 to 0.91).In this study level meta-analysis, SMuRF-less ACS patients demonstrate higher mortality compared with patients with at least one traditional atherosclerotic risk factor. Underuse of guideline-directed medical therapy amongst SMuRF-less patients is concerning. Unraveling novel risk factors amongst SMuRF-less individuals is the next important step.CONCLUSIONIn this study level meta-analysis, SMuRF-less ACS patients demonstrate higher mortality compared with patients with at least one traditional atherosclerotic risk factor. Underuse of guideline-directed medical therapy amongst SMuRF-less patients is concerning. Unraveling novel risk factors amongst SMuRF-less individuals is the next important step.Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes mellitus, hyperlipidemia, hypertension, and smoking, are often used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Of 1,285,722 ACS patients, 11.56% were SMuRF-less. Despite lower body mass index and fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock. However, despite worse outcomes, SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge.SUMMARYStandard modifiable cardiovascular risk factors (SMuRF), comprising diabetes mellitus, hyperlipidemia, hypertension, and smoking, are often used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Of 1,285,722 ACS patients, 11.56% were SMuRF-less. Despite lower body mass index and fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock. However, despite worse outcomes, SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge. Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Embase, Medline and Pubmed were searched for studies comparing SMuRF-less and SMuRF patients with first presentation of ACS. We conducted single-arm analyses to determine the proportion of SMuRF-less patients in the ACS cohort, and compared the clinical presentation and outcomes of these patients. Of 1,285,722 patients from 15 studies, 11.56% were SMuRF-less. A total of 7.44% of non-ST-segment-elevation ACS patients and 12.87% of ST-segment-elevation myocardial infarction (STEMI) patients were SMuRF-less. The proportion of SMuRF-less patients presenting with STEMI (60.71%) tended to be higher than those with SMuRFs (49.21%). Despite lower body mass index and fewer comorbidities such as chronic kidney disease, peripheral arterial disease, stroke and heart failure, SMuRF-less patients had increased in-hospital mortality (RR:1.57, 95%CI:1.38 to 1.80) and cardiogenic shock (RR:1.39, 95%CI:1.18 to 1.65), but lower risk of heart failure (RR:0.91, 95%CI:0.83 to 0.99). On discharge, SMuRF-less patients were prescribed less statins (RR:0.93, 95%CI:0.91 to 0.95), beta-blockers (RR:0.94, 95%CI:0.92 to 0.96), P2Y12 inhibitors (RR: 0.98, 95%CI: 0.96 to 0.99), and angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (RR:0.92, 95%CI:0.75 to 0.91). In this study level meta-analysis, SMuRF-less ACS patients demonstrate higher mortality compared with patients with at least one traditional atherosclerotic risk factor. Underuse of guideline-directed medical therapy amongst SMuRF-less patients is concerning. Unraveling novel risk factors amongst SMuRF-less individuals is the next important step. Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes mellitus, hyperlipidemia, hypertension, and smoking, are often used for risk stratification in acute coronary syndrome (ACS). Recent studies showed an increasing proportion of SMuRF-less ACS patients. Of 1,285,722 ACS patients, 11.56% were SMuRF-less. Despite lower body mass index and fewer comorbidities, SMuRF-less patients had increased in-hospital mortality and cardiogenic shock. However, despite worse outcomes, SMuRF-less patients were prescribed less guideline-directed medical therapies on discharge. |
| Author | Goh, Rachel Sze Jen Chew, Nicholas W.S. Vernon, Stephen T. Kong, Gwyneth Ng, Cheng Han Muthiah, Mark Chan, Mark Y. Foo, Roger Figtree, Gemma A. Chong, Bryan Loh, Poay Huan Chin, Yip Han Lim, Oliver Zi Hern |
| Author_xml | – sequence: 1 givenname: Gwyneth surname: Kong fullname: Kong, Gwyneth organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 2 givenname: Yip Han surname: Chin fullname: Chin, Yip Han organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 3 givenname: Bryan surname: Chong fullname: Chong, Bryan organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 4 givenname: Rachel Sze Jen surname: Goh fullname: Goh, Rachel Sze Jen organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 5 givenname: Oliver Zi Hern surname: Lim fullname: Lim, Oliver Zi Hern organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 6 givenname: Cheng Han surname: Ng fullname: Ng, Cheng Han organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 7 givenname: Mark surname: Muthiah fullname: Muthiah, Mark organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 8 givenname: Roger surname: Foo fullname: Foo, Roger organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 9 givenname: Stephen T. surname: Vernon fullname: Vernon, Stephen T. organization: Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia – sequence: 10 givenname: Poay Huan surname: Loh fullname: Loh, Poay Huan organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 11 givenname: Mark Y. surname: Chan fullname: Chan, Mark Y. organization: Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 12 givenname: Nicholas W.S. surname: Chew fullname: Chew, Nicholas W.S. email: nicholas_ws_chew@nuhs.edu.sg organization: Department of Cardiology, National University Heart Centre, National University Health System, Singapore – sequence: 13 givenname: Gemma A. surname: Figtree fullname: Figtree, Gemma A. organization: Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36179904$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFvFCEYhompsdvqPzCGo4fOCgwDM40xMY1akyYmRs-EZT5atgyswGjmn_TnlmZbD73sicvzvMD7nqCjEAMg9JaSNSVUfNiu3dboNK4ZYWxNhjUR7AVa0V7yhsqOH6FVxWTTMdkeo5Oct4QQPgz9K3TcCiqHgfAVurt01zeQ8BRT0d6VBbuAtZkLYBNTDDotOC9hTHECvNPFQSgZ_3PlJs4F56LDWN9Q9dFZpzcecHL5FlttSkz5HP-EPPtq2BqANb72caM9nqDoRgftl-wyjhbTM9Z3Z5Kx_3e8Ri-t9hnePJ6n6PfXL78uLpurH9--X3y-agynXWksQC_aDet6OtC211wYSqyxlnIOHeWtsAMdDOmMlEQIA1xKO2gm2s52sqXtKXq_z92l-GeGXNTksgHvdYA4Z8UkI5z1XHQVffeIzpsJRrVLbqr9qKc2K3C-B0yKOSewyrhS_xNDSdp5RYl6mE5t1X469TCdIoOq01WZP5Of8g9on_Ya1JL-Okgqm1qggdElMEWN0R0K-PgswHgXnNH-FpbD-j05Dcoe |
| CitedBy_id | crossref_primary_10_1016_j_ahj_2023_05_023 crossref_primary_10_1016_j_jacasi_2023_11_001 crossref_primary_10_1093_eurjpc_zwae281 crossref_primary_10_1002_hsr2_70122 crossref_primary_10_3389_fmed_2023_1209625 crossref_primary_10_1016_j_cmet_2023_02_003 crossref_primary_10_1001_jamacardio_2024_5644 crossref_primary_10_1161_CIRCIMAGING_122_015159 crossref_primary_10_1016_j_ijcha_2024_101370 crossref_primary_10_1111_dom_14950 crossref_primary_10_1016_j_cjco_2023_11_019 crossref_primary_10_3390_jcm12144870 crossref_primary_10_1038_s41366_023_01321_5 crossref_primary_10_1016_j_hlc_2024_09_001 crossref_primary_10_1186_s12933_024_02345_5 crossref_primary_10_3389_fcvm_2023_1235667 crossref_primary_10_1002_advs_202406359 crossref_primary_10_1016_j_amjcard_2023_07_025 crossref_primary_10_1016_j_metabol_2023_155402 crossref_primary_10_1016_j_lanwpc_2024_101138 crossref_primary_10_1016_j_jacasi_2023_09_013 crossref_primary_10_1007_s00392_024_02563_7 crossref_primary_10_1161_CIRCIMAGING_123_015985 crossref_primary_10_1016_j_ajpc_2024_100672 crossref_primary_10_4239_wjd_v15_i1_34 crossref_primary_10_1016_j_diabres_2024_111652 crossref_primary_10_1007_s12928_024_01022_4 crossref_primary_10_1016_j_jacc_2023_06_045 crossref_primary_10_1002_ccd_31205 crossref_primary_10_1007_s12291_024_01188_x crossref_primary_10_1155_2024_3985731 crossref_primary_10_1093_eurheartj_ehae271 crossref_primary_10_1016_j_ijcha_2024_101393 crossref_primary_10_1093_eurjpc_zwad133 crossref_primary_10_1093_eurheartj_ehae190 crossref_primary_10_1186_s12916_025_03933_2 crossref_primary_10_1590_1806_9282_2024s114 crossref_primary_10_1186_s12916_023_02825_7 crossref_primary_10_3390_biom13081187 crossref_primary_10_1016_j_clnu_2024_05_019 crossref_primary_10_3390_cells11244136 crossref_primary_10_1016_j_amjcard_2023_02_023 crossref_primary_10_1161_CIRCOUTCOMES_122_009340 crossref_primary_10_3390_healthcare13060610 crossref_primary_10_1136_openhrt_2024_002733 crossref_primary_10_1016_j_amjcard_2023_06_045 crossref_primary_10_1186_s13098_024_01524_4 crossref_primary_10_1177_00033197241263399 crossref_primary_10_1016_j_ahjo_2024_100408 crossref_primary_10_1161_JAHA_122_029252 crossref_primary_10_1016_j_ijcard_2023_04_042 crossref_primary_10_1016_j_lanwpc_2023_100803 crossref_primary_10_1093_nutrit_nuad163 |
| Cites_doi | 10.1161/JAHA.121.024818 10.1016/j.cpcardiol.2022.101343 10.1177/2047487317720287 10.1016/j.cjca.2015.04.007 10.1016/j.jacc.2018.09.057 10.1001/jama.290.7.898 10.1016/S0140-6736(04)17018-9 10.1093/eurheartj/ehaa575 10.1016/j.jacc.2017.11.007 10.1161/HYPERTENSIONAHA.107.095497 10.1016/S0140-6736(95)90865-X 10.1016/j.amjcard.2021.10.032 10.1016/0197-2456(86)90046-2 10.3389/fcvm.2021.756810 10.1186/s12916-022-02418-w 10.3389/fcvm.2022.869168 10.1016/j.ahj.2006.12.018 10.1016/S0140-6736(02)11911-8 10.3389/fcvm.2022.934946 10.1056/NEJMoa043938 10.1186/s12874-020-00975-3 10.1093/eurjpc/zwaa146 10.1016/j.jcin.2022.03.036 10.1111/micc.12488 10.1093/eurheartj/ehab474 10.1186/1471-2288-14-135 10.2147/TCRM.S67945 10.1016/S0735-1097(13)60097-2 10.1016/j.hlc.2021.04.026 10.2105/AJPH.47.4_Pt_2.4 10.1111/j.1756-185X.2012.01712.x 10.1016/j.ahj.2005.05.019 10.1093/biomet/26.4.404 10.1016/j.pcad.2013.10.016 10.1016/S0140-6736(19)32008-2 10.1161/CIRCULATIONAHA.108.790048 10.1016/S0140-6736(21)00272-5 10.1161/01.cir.0000437741.48606.98 10.1161/JAHA.119.013296 10.1016/j.amjcard.2015.11.059 10.5551/jat1994.4.51 10.1016/j.jacc.2014.04.042 10.1016/S0140-6736(21)00375-5 10.1136/bmj.327.7414.557 10.1136/bmj.39057.406644.68 10.21101/cejph.a4351 10.15171/ijhpm.2014.71 10.1159/000337324 10.3904/kjim.2018.056 10.1016/j.amjcard.2005.04.029 10.1177/2047487316679522 10.1002/jrsm.1348 10.1111/j.1538-7836.2005.01204.x 10.1016/j.cpcardiol.2022.101271 10.1016/j.amepre.2011.10.026 |
| ContentType | Journal Article |
| Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ijcard.2022.09.062 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1874-1754 |
| EndPage | 440 |
| ExternalDocumentID | 36179904 10_1016_j_ijcard_2022_09_062 S0167527322014139 |
| Genre | Meta-Analysis Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M29 M41 MO0 N9A O-L O9- OA. OAUVE OL~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SAE SCC SDF SDG SEL SES SPCBC SSH SSZ T5K UV1 Z5R ~G- 0SF AACTN AFCTW AFKWA AHHHB AJOXV AMFUW .55 .GJ 29J AAQXK AAYWO AAYXX ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFFNX AGHFR AGQPQ AGRNS ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HEB HMK HMO HVGLF HZ~ R2- RIG SEW WUQ X7M ZGI CGR CUY CVF ECM EIF NPM 7X8 ACLOT EFLBG ~HD |
| ID | FETCH-LOGICAL-c415t-fee863b25819138a46c10fcff144e51436f919c05c77066ce477f9a2635f57313 |
| IEDL.DBID | .~1 |
| ISSN | 0167-5273 1874-1754 |
| IngestDate | Sat Sep 27 23:55:16 EDT 2025 Wed Feb 19 02:25:01 EST 2025 Tue Jul 01 04:04:33 EDT 2025 Thu Apr 24 22:50:09 EDT 2025 Tue Dec 03 03:44:46 EST 2024 Tue Aug 26 16:54:36 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | SMuRF ST-segment elevation myocardial infarction Mortality Risk factor Atherosclerosis |
| Language | English |
| License | Copyright © 2022 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c415t-fee863b25819138a46c10fcff144e51436f919c05c77066ce477f9a2635f57313 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 36179904 |
| PQID | 2720428465 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2720428465 pubmed_primary_36179904 crossref_citationtrail_10_1016_j_ijcard_2022_09_062 crossref_primary_10_1016_j_ijcard_2022_09_062 elsevier_sciencedirect_doi_10_1016_j_ijcard_2022_09_062 elsevier_clinicalkey_doi_10_1016_j_ijcard_2022_09_062 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-15 |
| PublicationDateYYYYMMDD | 2023-01-15 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | International journal of cardiology |
| PublicationTitleAlternate | Int J Cardiol |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Wan, Wang, Liu, Tong (bb0060) 2014; 14 Choi, Jeong, Hong, Sohn, Kook, Sim (bb0205) 2019; 34 Vernon, Hansen, Kott, Yang, O’Sullivan, Figtree (bb0285) 2019; 26 Figtree, Vernon, Hadziosmanovic, Sundström, Alfredsson, Nicholls (bb0150) 2022; 11 Members, Piepoli, Hoes, Agewall, Albus, Brotons (bb0290) 2016; 37 Dawber, Moore, Mann (bb0005) 1957; 47 Fonarow, Wright, Spencer, Fredrick, Dong, Every (bb0240) 2005; 96 Perkovic, Huxley, Wu, Prabhakaran, MacMahon (bb0340) 2007; 50 Vernon, Coffey, D’Souza, Chow, Kilian, Hyun (bb0180) 2019; 8 Clopper, Pearson (bb0085) 1934; 26 Avis, Vernon, Hagström, Figtree (bb0330) 2021 Goff, Lloyd-Jones, Bennett, Coady, D’Agostino, Gibbons (bb0295) 2014; 129 Collet, Thiele, Barbato, Barthélémy, Bauersachs, Bhatt (bb0265) 2021; 42 Fletcher (bb0110) 2007; 334 Khot, Khot, Bajzer, Sapp, Ohman, Brener (bb0170) 2003; 290 Finkelstein, Khavjou, Thompson, Trogdon, Pan, Sherry (bb0190) 2012; 42 Li, Gao, Yang, Xu, Wang, Zhao (bb0125) 2022; 20 Solomon, Zelenkofske, McMurray, Finn, Velazquez, Ertl (bb0320) 2005; 352 Yamamoto, Natsuaki, Morimoto, Shiomi, Takeji, Yamaji (bb0135) 2022; 164 Marceau, Samson, Laflamme, Rinfret (bb0235) 2013; 61 Roe, Halabi, Mehta, Chen, Kristin Newby, Harrington (bb0025) 2007; 153 Keng Siang Lee, Nga, Ng, Tai, Higgins, Syn (bb0100) 2021; 161 Vernon, Coffey, Bhindi, Soo Hoo, Nelson, Ward (bb0015) 2020; 24 Vernon, Coffey, Bhindi, Soo Hoo, Nelson, Ward (bb0175) 2017; 24 Munn, Moola, Riitano, Lisy (bb0070) 2014; 3 Gwyneth, Nicholas, Cheng Han, Yeung Jek, Aaron, Oliver (bb0155) 2022; 9 Yusuf, Hawken, Ounpuu, Dans, Avezum, Lanas (bb0210) 2004; 364 Dawber, Moore, Mann (bb0050) 1957; 47 Higgins, Thompson, Deeks, Altman (bb0105) 2003; 327 Group. FISoISC (bb0245) 1995; 345 Avis, Vernon, Hagstrom, Figtree (bb0030) 2021; 42 Allen, O’Donnell, Camargo, Giugliano, Lloyd-Jones (bb0230) 2006; 151 Collaboration (bb0355) 2002; 360 Sarkees, Bavry (bb0045) 2010; 2010 Quek, Lim, Lim, Ng, So, Toh (bb0220) 2021; 8 Hansen, Peytz, Blokstra, Bojesen, Celis-Morales, Chrysohoou (bb0225) 2021; 28 Avis, Vernon, Hagstrom, Figtree (bb0020) 2021; 42 Kong, Chew, Ng, Chin, Lim, Ambhore (bb0310) 2022; 9 Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow (bb0040) 2021; 372 Schwarzer, Chemaitelly, Abu-Raddad, Rücker (bb0080) 2019; 10 Playford, Hamilton-Craig, Dwivedi, Figtree (bb0305) 2021; 30 Papazoglou, Farmakis, Zafeiropoulos, Moysidis, Karagiannidis, Stalikas (bb0130) 2022; 9 Piironen, Ukkola, Huikuri, Havulinna, Koukkunen, Mustonen (bb0010) 2017; 24 Wang, Goodman, Saltzman, Wong, Huynh, Dery (bb0120) 2015; 31 Yusuf, Joseph, Rangarajan, Islam, Mente, Hystad (bb0215) 2020; 395 Andersson, Shilane, Go, Chang, Kazi, Solomon (bb0250) 2014; 64 González-Pacheco, Vargas-Barrón, Vallejo, Piña-Reyna, Altamirano-Castillo, Sánchez-Tapia (bb0140) 2014; 10 Shamaki, Safiriyu, Kesiena, Mbachi, Anyanwu, Zahid (bb0160) 2022; 47 Bugiardini, Cenko, Ricci, Vasiljevic, Dorobantu, Kedev (bb0255) 2016; 117 Cheung, Ho, Lim, Mak (bb0095) 2012; 15 Shrestha, Mochon, Poudel, Poudel, Donato (bb0165) 2022; 47 Ueshima, Sekikawa, Miura, Turin, Takashima, Kita (bb0345) 2008; 118 Iliodromitis, Lazou, Kremastinos (bb0275) 2007; 3 Bastien, Poirier, Lemieux, Després (bb0195) 2014; 56 Yusuf, Hawken, Ôunpuu, Dans, Avezum, Lanas (bb0185) 2004; 364 Vernon, Coffey, D’Souza, Chow, Kilian, Hyun (bb0055) 2019; 8 Alberty, Studenčan, Kovář (bb0145) 2017; 25 Figtree, Vernon (bb0325) 2021 Mendis, Abegunde, Yusuf, Ebrahim, Shaper, Ghannem (bb0350) 2005; 83 Alliance (bb0300) 2012 Capodanno, Alfonso, Levine Glenn, Valgimigli, Angiolillo (bb0260) 2018; 72 DerSimonian, Laird (bb0090) 1986; 7 Cullen, Funke, Schulte, Assmann (bb0335) 1997; 4 Lønnebakken (bb0035) 2021; 397 Borges Migliavaca, Stein, Colpani, Barker, Munn, Falavigna (bb0075) 2020; 20 Erne, Gutzwiller, Urban, Maggiorini, Keller, Radovanovic (bb0200) 2012; 121 DerSimonian, Laird (bb0115) 1986; 7 Singh, Collins, Gupta, Fatima, Qamar, Biery (bb0270) 2018; 71 Figtree, Vernon, Hadziosmanovic, Sundström, Alfredsson, Arnott (bb0315) 2021; 397 Schulman, Kearon (bb0065) 2005; 3 Figtree Gemma, Redfors, Kozor, Vernon Stephen, Grieve Stuart, Mazhar (bb0280) 2022; 15 Page (10.1016/j.ijcard.2022.09.062_bb0040) 2021; 372 Li (10.1016/j.ijcard.2022.09.062_bb0125) 2022; 20 Erne (10.1016/j.ijcard.2022.09.062_bb0200) 2012; 121 Lønnebakken (10.1016/j.ijcard.2022.09.062_bb0035) 2021; 397 Figtree (10.1016/j.ijcard.2022.09.062_bb0325) 2021 Vernon (10.1016/j.ijcard.2022.09.062_bb0180) 2019; 8 Higgins (10.1016/j.ijcard.2022.09.062_bb0105) 2003; 327 Figtree Gemma (10.1016/j.ijcard.2022.09.062_bb0280) 2022; 15 Members (10.1016/j.ijcard.2022.09.062_bb0290) 2016; 37 Dawber (10.1016/j.ijcard.2022.09.062_bb0005) 1957; 47 Munn (10.1016/j.ijcard.2022.09.062_bb0070) 2014; 3 Group. FISoISC (10.1016/j.ijcard.2022.09.062_bb0245) 1995; 345 Vernon (10.1016/j.ijcard.2022.09.062_bb0055) 2019; 8 Borges Migliavaca (10.1016/j.ijcard.2022.09.062_bb0075) 2020; 20 Vernon (10.1016/j.ijcard.2022.09.062_bb0175) 2017; 24 Singh (10.1016/j.ijcard.2022.09.062_bb0270) 2018; 71 Figtree (10.1016/j.ijcard.2022.09.062_bb0150) 2022; 11 Alliance (10.1016/j.ijcard.2022.09.062_bb0300) 2012 Kong (10.1016/j.ijcard.2022.09.062_bb0310) 2022; 9 Wan (10.1016/j.ijcard.2022.09.062_bb0060) 2014; 14 Choi (10.1016/j.ijcard.2022.09.062_bb0205) 2019; 34 DerSimonian (10.1016/j.ijcard.2022.09.062_bb0090) 1986; 7 Avis (10.1016/j.ijcard.2022.09.062_bb0020) 2021; 42 Bastien (10.1016/j.ijcard.2022.09.062_bb0195) 2014; 56 Alberty (10.1016/j.ijcard.2022.09.062_bb0145) 2017; 25 Papazoglou (10.1016/j.ijcard.2022.09.062_bb0130) 2022; 9 González-Pacheco (10.1016/j.ijcard.2022.09.062_bb0140) 2014; 10 Andersson (10.1016/j.ijcard.2022.09.062_bb0250) 2014; 64 Capodanno (10.1016/j.ijcard.2022.09.062_bb0260) 2018; 72 Finkelstein (10.1016/j.ijcard.2022.09.062_bb0190) 2012; 42 DerSimonian (10.1016/j.ijcard.2022.09.062_bb0115) 1986; 7 Mendis (10.1016/j.ijcard.2022.09.062_bb0350) 2005; 83 Cheung (10.1016/j.ijcard.2022.09.062_bb0095) 2012; 15 Hansen (10.1016/j.ijcard.2022.09.062_bb0225) 2021; 28 Fonarow (10.1016/j.ijcard.2022.09.062_bb0240) 2005; 96 Wang (10.1016/j.ijcard.2022.09.062_bb0120) 2015; 31 Vernon (10.1016/j.ijcard.2022.09.062_bb0015) 2020; 24 Shrestha (10.1016/j.ijcard.2022.09.062_bb0165) 2022; 47 Allen (10.1016/j.ijcard.2022.09.062_bb0230) 2006; 151 Avis (10.1016/j.ijcard.2022.09.062_bb0330) 2021 Yusuf (10.1016/j.ijcard.2022.09.062_bb0215) 2020; 395 Piironen (10.1016/j.ijcard.2022.09.062_bb0010) 2017; 24 Keng Siang Lee (10.1016/j.ijcard.2022.09.062_bb0100) 2021; 161 Khot (10.1016/j.ijcard.2022.09.062_bb0170) 2003; 290 Avis (10.1016/j.ijcard.2022.09.062_bb0030) 2021; 42 Iliodromitis (10.1016/j.ijcard.2022.09.062_bb0275) 2007; 3 Clopper (10.1016/j.ijcard.2022.09.062_bb0085) 1934; 26 Schulman (10.1016/j.ijcard.2022.09.062_bb0065) 2005; 3 Quek (10.1016/j.ijcard.2022.09.062_bb0220) 2021; 8 Bugiardini (10.1016/j.ijcard.2022.09.062_bb0255) 2016; 117 Fletcher (10.1016/j.ijcard.2022.09.062_bb0110) 2007; 334 Cullen (10.1016/j.ijcard.2022.09.062_bb0335) 1997; 4 Collaboration (10.1016/j.ijcard.2022.09.062_bb0355) 2002; 360 Sarkees (10.1016/j.ijcard.2022.09.062_bb0045) 2010; 2010 Marceau (10.1016/j.ijcard.2022.09.062_bb0235) 2013; 61 Vernon (10.1016/j.ijcard.2022.09.062_bb0285) 2019; 26 Dawber (10.1016/j.ijcard.2022.09.062_bb0050) 1957; 47 Perkovic (10.1016/j.ijcard.2022.09.062_bb0340) 2007; 50 Schwarzer (10.1016/j.ijcard.2022.09.062_bb0080) 2019; 10 Yamamoto (10.1016/j.ijcard.2022.09.062_bb0135) 2022; 164 Goff (10.1016/j.ijcard.2022.09.062_bb0295) 2014; 129 Roe (10.1016/j.ijcard.2022.09.062_bb0025) 2007; 153 Yusuf (10.1016/j.ijcard.2022.09.062_bb0185) 2004; 364 Solomon (10.1016/j.ijcard.2022.09.062_bb0320) 2005; 352 Gwyneth (10.1016/j.ijcard.2022.09.062_bb0155) 2022; 9 Playford (10.1016/j.ijcard.2022.09.062_bb0305) 2021; 30 Collet (10.1016/j.ijcard.2022.09.062_bb0265) 2021; 42 Ueshima (10.1016/j.ijcard.2022.09.062_bb0345) 2008; 118 Yusuf (10.1016/j.ijcard.2022.09.062_bb0210) 2004; 364 Shamaki (10.1016/j.ijcard.2022.09.062_bb0160) 2022; 47 Figtree (10.1016/j.ijcard.2022.09.062_bb0315) 2021; 397 36306947 - Int J Cardiol. 2023 Jan 1;370:83 |
| References_xml | – volume: 64 start-page: 247 year: 2014 end-page: 252 ident: bb0250 article-title: β-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease publication-title: J. Am. Coll. Cardiol. – volume: 47 start-page: 4 year: 1957 end-page: 24 ident: bb0005 article-title: Coronary heart disease in the Framingham study publication-title: Am J Public Health Nations Health. – volume: 397 start-page: 1085 year: 2021 end-page: 1094 ident: bb0315 article-title: Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data publication-title: Lancet – volume: 24 start-page: 1824 year: 2020 end-page: 1830 ident: bb0015 article-title: Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors publication-title: Eur. J. Prev. Cardiol. – volume: 11 year: 2022 ident: bb0150 article-title: Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry publication-title: J. Am. Heart Assoc. – volume: 121 start-page: 228 year: 2012 end-page: 236 ident: bb0200 article-title: Characteristics and outcome in acute coronary syndrome patients with and without established modifiable cardiovascular risk factors: insights from the Nationwide AMIS plus registry 1997–2010 publication-title: Cardiology. – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bb0090 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials – volume: 9 start-page: 869168 year: 2022 ident: bb0155 article-title: Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multi-ethnic study of 8680 Asian patients publication-title: Front Cardiovasc Med – volume: 8 year: 2019 ident: bb0180 article-title: ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? publication-title: J. Am. Heart Assoc. – volume: 10 start-page: 476 year: 2019 end-page: 483 ident: bb0080 article-title: Seriously misleading results using inverse of freeman-Tukey double arcsine transformation in meta-analysis of single proportions publication-title: Res. Synth. Methods – volume: 96 start-page: 611 year: 2005 end-page: 616 ident: bb0240 article-title: Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality publication-title: Am. J. Cardiol. – volume: 118 start-page: 2702 year: 2008 end-page: 2709 ident: bb0345 article-title: Cardiovascular disease and risk factors in Asia: a selected review publication-title: Circulation. – volume: 364 start-page: 937 year: 2004 end-page: 952 ident: bb0210 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet. – volume: 364 start-page: 937 year: 2004 end-page: 952 ident: bb0185 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet – volume: 37 start-page: 2315 year: 2016 end-page: 2381 ident: bb0290 article-title: European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR) publication-title: Eur. J. Prev. Cardiol. – volume: 71 start-page: 292 year: 2018 end-page: 302 ident: bb0270 article-title: Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry publication-title: J. Am. Coll. Cardiol. – volume: 30 start-page: 1819 year: 2021 end-page: 1828 ident: bb0305 article-title: Examining the potential for coronary artery calcium (cac) scoring for individuals at low cardiovascular risk publication-title: Heart, Lung and Circulation – volume: 14 start-page: 135 year: 2014 ident: bb0060 article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range publication-title: BMC Med. Res. Methodol. – volume: 161 start-page: 291 year: 2021 end-page: 302.e1 ident: bb0100 article-title: Tenets for the proper conduct and use of meta-analyses: a practical guide for neurosurgeons publication-title: World Neurosurg. – year: 2021 ident: bb0330 article-title: Coronary Artery Disease in the Absence of Traditional Risk Factors: A Call for Action – volume: 47 start-page: 4 year: 1957 end-page: 24 ident: bb0050 article-title: Coronary heart disease in the Framingham study publication-title: American Journal of Public Health and the Nations Health. – volume: 50 start-page: 991 year: 2007 end-page: 997 ident: bb0340 article-title: The burden of blood pressure-related disease: a neglected priority for global health publication-title: Hypertension. – year: 2021 ident: bb0325 article-title: Coronary Artery Disease Patients without Standard Modifiable Risk Factors (SMuRFs)-a Forgotten Group Calling out for New Discoveries – volume: 2010 year: 2010 ident: bb0045 article-title: Non ST-elevation acute coronary syndrome publication-title: BMJ clinical evidence. – volume: 15 start-page: 1167 year: 2022 end-page: 1175 ident: bb0280 article-title: Clinical outcomes in patients with ST-segment elevation MI and no standard modifiable cardiovascular risk factors publication-title: J. Am. Coll. Cardiol. Intv. – volume: 25 start-page: 77 year: 2017 end-page: 84 ident: bb0145 article-title: Prevalence of conventional cardiovascular risk factors in patients with acute coronary syndromes in Slovakia publication-title: Cent. Eur. J. Public Health – volume: 164 start-page: 34 year: 2022 end-page: 43 ident: bb0135 article-title: Coronary artery disease without standard cardiovascular risk factors publication-title: Am. J. Cardiol. – volume: 26 start-page: 404 year: 1934 end-page: 413 ident: bb0085 article-title: The use of confidence or fiducial limits illustrated in the case of the binomial publication-title: Biometrika. – volume: 83 start-page: 820 year: 2005 end-page: 829 ident: bb0350 article-title: WHO study on prevention of REcurrences of myocardial infarction and StrokE (WHO-PREMISE) publication-title: Bull. World Health Organ. – volume: 47 year: 2022 ident: bb0165 article-title: Trends and outcomes of ST-segment-elevation MI in hospitalized patients without standard modifiable cardiovascular risk factors publication-title: Curr. Probl. Cardiol. – volume: 372 year: 2021 ident: bb0040 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ. – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bb0115 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials – volume: 327 start-page: 557 year: 2003 end-page: 560 ident: bb0105 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – volume: 26 year: 2019 ident: bb0285 article-title: Utilizing state-of-the-art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease publication-title: Microcirculation. – volume: 42 start-page: 1289 year: 2021 end-page: 1367 ident: bb0265 article-title: 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur. Heart J. – volume: 3 start-page: 692 year: 2005 end-page: 694 ident: bb0065 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients publication-title: J. Thromb. Haemost. – volume: 129 start-page: S49 year: 2014 end-page: S73 ident: bb0295 article-title: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines publication-title: Circulation. – volume: 42 start-page: 563 year: 2012 end-page: 570 ident: bb0190 article-title: Obesity and severe obesity forecasts through 2030 publication-title: Am. J. Prev. Med. – volume: 10 start-page: 815 year: 2014 end-page: 823 ident: bb0140 article-title: Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease publication-title: Ther. Clin. Risk Manag. – volume: 28 start-page: 1590 year: 2021 end-page: 1598 ident: bb0225 article-title: Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies publication-title: Eur. J. Prev. Cardiol. – volume: 290 start-page: 898 year: 2003 end-page: 904 ident: bb0170 article-title: Prevalence of conventional risk factors in patients with coronary heart disease publication-title: JAMA. – volume: 24 start-page: 1824 year: 2017 end-page: 1830 ident: bb0175 article-title: Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors publication-title: Eur. J. Prev. Cardiol. – volume: 151 start-page: 1065 year: 2006 end-page: 1071 ident: bb0230 article-title: Comparison of long-term mortality across the spectrum of acute coronary syndromes publication-title: Am. Heart J. – volume: 9 year: 2022 ident: bb0130 article-title: Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors publication-title: Front Cardiovasc Med. – year: 2012 ident: bb0300 article-title: Guidelines for the Management of Absolute CVD Risk 2012 – volume: 20 start-page: 96 year: 2020 ident: bb0075 article-title: How are systematic reviews of prevalence conducted? A methodological study publication-title: BMC Med. Res. Methodol. – volume: 56 start-page: 369 year: 2014 end-page: 381 ident: bb0195 article-title: Overview of epidemiology and contribution of obesity to cardiovascular disease publication-title: Prog. Cardiovasc. Dis. – volume: 360 start-page: 1903 year: 2002 end-page: 1913 ident: bb0355 article-title: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies publication-title: Lancet – volume: 334 start-page: 94 year: 2007 end-page: 96 ident: bb0110 article-title: What is heterogeneity and is it important? publication-title: BMJ. – volume: 395 start-page: 795 year: 2020 end-page: 808 ident: bb0215 article-title: Modifiable risk factors, cardiovascular disease, and mortality in 155 publication-title: Lancet. – volume: 9 year: 2022 ident: bb0310 article-title: Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8,680 Asian patients publication-title: Front Cardiovasc Med. – volume: 3 start-page: 629 year: 2007 ident: bb0275 article-title: Ischemic preconditioning: protection against myocardial necrosis and apoptosis publication-title: Vasc. Health Risk Manag. – volume: 42 start-page: 3822 year: 2021 end-page: 3824 ident: bb0030 article-title: Coronary artery disease in the absence of traditional risk factors: a call for action publication-title: Eur. Heart J. – volume: 72 start-page: 2915 year: 2018 end-page: 2931 ident: bb0260 article-title: ACC/AHA versus ESC guidelines on dual antiplatelet therapy publication-title: J. Am. Coll. Cardiol. – volume: 47 year: 2022 ident: bb0160 article-title: Prevalence and outcomes in STEMI patients without standard modifiable cardiovascular risk factors: a National Inpatient Sample Analysis publication-title: Curr. Probl. Cardiol. – volume: 20 start-page: 217 year: 2022 ident: bb0125 article-title: Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China acute myocardial infarction registry publication-title: BMC Med. – volume: 15 start-page: 129 year: 2012 end-page: 135 ident: bb0095 article-title: Conducting a meta-analysis: basics and good practices publication-title: Int. J. Rheum. Dis. – volume: 8 year: 2019 ident: bb0055 article-title: ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? publication-title: J. Am. Heart Assoc. – volume: 31 start-page: 1455 year: 2015 end-page: 1461 ident: bb0120 article-title: Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian global registry of acute coronary events publication-title: Can. J. Cardiol. – volume: 24 start-page: 274 year: 2017 end-page: 280 ident: bb0010 article-title: Trends in long-term prognosis after acute coronary syndrome publication-title: Eur. J. Prev. Cardiol. – volume: 397 start-page: 1039 year: 2021 end-page: 1040 ident: bb0035 article-title: The risk of no risk in STEMI publication-title: Lancet – volume: 8 year: 2021 ident: bb0220 article-title: The Association of Plant-Based Diet with Cardiovascular Disease and Mortality: a Meta-analysis and systematic review of Prospect cohort studies publication-title: Front Cardiovasc Med. – volume: 61 year: 2013 ident: bb0235 article-title: Short and long-term mortality after STEMI versus non-STEMI: a systematic review and META-analysis publication-title: J. Am. Coll. Cardiol. – volume: 3 start-page: 123 year: 2014 end-page: 128 ident: bb0070 article-title: The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence publication-title: Int. J. Health Policy Manag. – volume: 352 start-page: 2581 year: 2005 end-page: 2588 ident: bb0320 article-title: Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both publication-title: N. Engl. J. Med. – volume: 345 start-page: 669 year: 1995 end-page: 685 ident: bb0245 article-title: ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (fourth international study of infarct survival) collaborative group publication-title: Lancet. – volume: 4 start-page: 51 year: 1997 end-page: 58 ident: bb0335 article-title: Lipoproteins and cardiovascular risk-from genetics to CHD prevention publication-title: J. Atheroscler. Thromb. – volume: 42 start-page: 3822 year: 2021 end-page: 3824 ident: bb0020 article-title: Coronary artery disease in the absence of traditional risk factors: a call for action publication-title: Eur. Heart J. – volume: 153 start-page: 507 year: 2007 end-page: 514 ident: bb0025 article-title: Documented traditional cardiovascular risk factors and mortality in non–ST-segment elevation myocardial infarction publication-title: Am. Heart J. – volume: 34 start-page: 1040 year: 2019 ident: bb0205 article-title: Clinical characteristics and outcomes in acute myocardial infarction patients with versus without any cardiovascular risk factors publication-title: The Korean journal of internal medicine. – volume: 117 start-page: 760 year: 2016 end-page: 767 ident: bb0255 article-title: Comparison of early versus delayed Oral β blockers in acute coronary syndromes and effect on outcomes publication-title: Am. J. Cardiol. – volume: 161 start-page: 291 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0100 article-title: Tenets for the proper conduct and use of meta-analyses: a practical guide for neurosurgeons publication-title: World Neurosurg. – volume: 11 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0150 article-title: Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.121.024818 – volume: 47 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0160 article-title: Prevalence and outcomes in STEMI patients without standard modifiable cardiovascular risk factors: a National Inpatient Sample Analysis publication-title: Curr. Probl. Cardiol. doi: 10.1016/j.cpcardiol.2022.101343 – volume: 24 start-page: 1824 year: 2017 ident: 10.1016/j.ijcard.2022.09.062_bb0175 article-title: Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487317720287 – volume: 31 start-page: 1455 year: 2015 ident: 10.1016/j.ijcard.2022.09.062_bb0120 article-title: Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian global registry of acute coronary events publication-title: Can. J. Cardiol. doi: 10.1016/j.cjca.2015.04.007 – volume: 72 start-page: 2915 year: 2018 ident: 10.1016/j.ijcard.2022.09.062_bb0260 article-title: ACC/AHA versus ESC guidelines on dual antiplatelet therapy publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2018.09.057 – volume: 290 start-page: 898 year: 2003 ident: 10.1016/j.ijcard.2022.09.062_bb0170 article-title: Prevalence of conventional risk factors in patients with coronary heart disease publication-title: JAMA. doi: 10.1001/jama.290.7.898 – volume: 364 start-page: 937 year: 2004 ident: 10.1016/j.ijcard.2022.09.062_bb0185 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet doi: 10.1016/S0140-6736(04)17018-9 – volume: 42 start-page: 1289 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0265 article-title: 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehaa575 – volume: 71 start-page: 292 year: 2018 ident: 10.1016/j.ijcard.2022.09.062_bb0270 article-title: Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.11.007 – volume: 50 start-page: 991 year: 2007 ident: 10.1016/j.ijcard.2022.09.062_bb0340 article-title: The burden of blood pressure-related disease: a neglected priority for global health publication-title: Hypertension. doi: 10.1161/HYPERTENSIONAHA.107.095497 – volume: 345 start-page: 669 year: 1995 ident: 10.1016/j.ijcard.2022.09.062_bb0245 publication-title: Lancet. doi: 10.1016/S0140-6736(95)90865-X – volume: 164 start-page: 34 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0135 article-title: Coronary artery disease without standard cardiovascular risk factors publication-title: Am. J. Cardiol. doi: 10.1016/j.amjcard.2021.10.032 – volume: 7 start-page: 177 year: 1986 ident: 10.1016/j.ijcard.2022.09.062_bb0115 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 8 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0220 article-title: The Association of Plant-Based Diet with Cardiovascular Disease and Mortality: a Meta-analysis and systematic review of Prospect cohort studies publication-title: Front Cardiovasc Med. doi: 10.3389/fcvm.2021.756810 – volume: 2010 year: 2010 ident: 10.1016/j.ijcard.2022.09.062_bb0045 article-title: Non ST-elevation acute coronary syndrome publication-title: BMJ clinical evidence. – volume: 7 start-page: 177 year: 1986 ident: 10.1016/j.ijcard.2022.09.062_bb0090 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 20 start-page: 217 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0125 article-title: Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China acute myocardial infarction registry publication-title: BMC Med. doi: 10.1186/s12916-022-02418-w – volume: 9 start-page: 869168 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0155 article-title: Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multi-ethnic study of 8680 Asian patients publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2022.869168 – volume: 153 start-page: 507 year: 2007 ident: 10.1016/j.ijcard.2022.09.062_bb0025 article-title: Documented traditional cardiovascular risk factors and mortality in non–ST-segment elevation myocardial infarction publication-title: Am. Heart J. doi: 10.1016/j.ahj.2006.12.018 – volume: 360 start-page: 1903 year: 2002 ident: 10.1016/j.ijcard.2022.09.062_bb0355 article-title: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies publication-title: Lancet doi: 10.1016/S0140-6736(02)11911-8 – volume: 9 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0130 article-title: Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors publication-title: Front Cardiovasc Med. doi: 10.3389/fcvm.2022.934946 – volume: 352 start-page: 2581 year: 2005 ident: 10.1016/j.ijcard.2022.09.062_bb0320 article-title: Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa043938 – volume: 20 start-page: 96 year: 2020 ident: 10.1016/j.ijcard.2022.09.062_bb0075 article-title: How are systematic reviews of prevalence conducted? A methodological study publication-title: BMC Med. Res. Methodol. doi: 10.1186/s12874-020-00975-3 – volume: 28 start-page: 1590 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0225 article-title: Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies publication-title: Eur. J. Prev. Cardiol. doi: 10.1093/eurjpc/zwaa146 – volume: 15 start-page: 1167 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0280 article-title: Clinical outcomes in patients with ST-segment elevation MI and no standard modifiable cardiovascular risk factors publication-title: J. Am. Coll. Cardiol. Intv. doi: 10.1016/j.jcin.2022.03.036 – volume: 26 year: 2019 ident: 10.1016/j.ijcard.2022.09.062_bb0285 article-title: Utilizing state-of-the-art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease publication-title: Microcirculation. doi: 10.1111/micc.12488 – volume: 42 start-page: 3822 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0020 article-title: Coronary artery disease in the absence of traditional risk factors: a call for action publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab474 – volume: 14 start-page: 135 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0060 article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range publication-title: BMC Med. Res. Methodol. doi: 10.1186/1471-2288-14-135 – volume: 10 start-page: 815 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0140 article-title: Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease publication-title: Ther. Clin. Risk Manag. doi: 10.2147/TCRM.S67945 – volume: 61 year: 2013 ident: 10.1016/j.ijcard.2022.09.062_bb0235 article-title: Short and long-term mortality after STEMI versus non-STEMI: a systematic review and META-analysis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/S0735-1097(13)60097-2 – volume: 30 start-page: 1819 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0305 article-title: Examining the potential for coronary artery calcium (cac) scoring for individuals at low cardiovascular risk publication-title: Heart, Lung and Circulation doi: 10.1016/j.hlc.2021.04.026 – volume: 47 start-page: 4 year: 1957 ident: 10.1016/j.ijcard.2022.09.062_bb0050 article-title: Coronary heart disease in the Framingham study publication-title: American Journal of Public Health and the Nations Health. doi: 10.2105/AJPH.47.4_Pt_2.4 – volume: 15 start-page: 129 year: 2012 ident: 10.1016/j.ijcard.2022.09.062_bb0095 article-title: Conducting a meta-analysis: basics and good practices publication-title: Int. J. Rheum. Dis. doi: 10.1111/j.1756-185X.2012.01712.x – volume: 151 start-page: 1065 year: 2006 ident: 10.1016/j.ijcard.2022.09.062_bb0230 article-title: Comparison of long-term mortality across the spectrum of acute coronary syndromes publication-title: Am. Heart J. doi: 10.1016/j.ahj.2005.05.019 – volume: 364 start-page: 937 year: 2004 ident: 10.1016/j.ijcard.2022.09.062_bb0210 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet. doi: 10.1016/S0140-6736(04)17018-9 – volume: 26 start-page: 404 year: 1934 ident: 10.1016/j.ijcard.2022.09.062_bb0085 article-title: The use of confidence or fiducial limits illustrated in the case of the binomial publication-title: Biometrika. doi: 10.1093/biomet/26.4.404 – volume: 56 start-page: 369 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0195 article-title: Overview of epidemiology and contribution of obesity to cardiovascular disease publication-title: Prog. Cardiovasc. Dis. doi: 10.1016/j.pcad.2013.10.016 – volume: 395 start-page: 795 year: 2020 ident: 10.1016/j.ijcard.2022.09.062_bb0215 article-title: Modifiable risk factors, cardiovascular disease, and mortality in 155722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study publication-title: Lancet. doi: 10.1016/S0140-6736(19)32008-2 – year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0325 – volume: 118 start-page: 2702 year: 2008 ident: 10.1016/j.ijcard.2022.09.062_bb0345 article-title: Cardiovascular disease and risk factors in Asia: a selected review publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.108.790048 – volume: 397 start-page: 1085 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0315 article-title: Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data publication-title: Lancet doi: 10.1016/S0140-6736(21)00272-5 – volume: 129 start-page: S49 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0295 article-title: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines publication-title: Circulation. doi: 10.1161/01.cir.0000437741.48606.98 – volume: 8 year: 2019 ident: 10.1016/j.ijcard.2022.09.062_bb0180 article-title: ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.119.013296 – volume: 117 start-page: 760 year: 2016 ident: 10.1016/j.ijcard.2022.09.062_bb0255 article-title: Comparison of early versus delayed Oral β blockers in acute coronary syndromes and effect on outcomes publication-title: Am. J. Cardiol. doi: 10.1016/j.amjcard.2015.11.059 – year: 2012 ident: 10.1016/j.ijcard.2022.09.062_bb0300 – volume: 4 start-page: 51 year: 1997 ident: 10.1016/j.ijcard.2022.09.062_bb0335 article-title: Lipoproteins and cardiovascular risk-from genetics to CHD prevention publication-title: J. Atheroscler. Thromb. doi: 10.5551/jat1994.4.51 – volume: 64 start-page: 247 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0250 article-title: β-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2014.04.042 – volume: 42 start-page: 3822 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0030 article-title: Coronary artery disease in the absence of traditional risk factors: a call for action publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab474 – volume: 397 start-page: 1039 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0035 article-title: The risk of no risk in STEMI publication-title: Lancet doi: 10.1016/S0140-6736(21)00375-5 – volume: 327 start-page: 557 year: 2003 ident: 10.1016/j.ijcard.2022.09.062_bb0105 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 83 start-page: 820 year: 2005 ident: 10.1016/j.ijcard.2022.09.062_bb0350 article-title: WHO study on prevention of REcurrences of myocardial infarction and StrokE (WHO-PREMISE) publication-title: Bull. World Health Organ. – volume: 334 start-page: 94 year: 2007 ident: 10.1016/j.ijcard.2022.09.062_bb0110 article-title: What is heterogeneity and is it important? publication-title: BMJ. doi: 10.1136/bmj.39057.406644.68 – volume: 25 start-page: 77 year: 2017 ident: 10.1016/j.ijcard.2022.09.062_bb0145 article-title: Prevalence of conventional cardiovascular risk factors in patients with acute coronary syndromes in Slovakia publication-title: Cent. Eur. J. Public Health doi: 10.21101/cejph.a4351 – volume: 3 start-page: 123 year: 2014 ident: 10.1016/j.ijcard.2022.09.062_bb0070 article-title: The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence publication-title: Int. J. Health Policy Manag. doi: 10.15171/ijhpm.2014.71 – volume: 37 start-page: 2315 year: 2016 ident: 10.1016/j.ijcard.2022.09.062_bb0290 publication-title: Eur. J. Prev. Cardiol. – volume: 372 year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0040 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ. – volume: 8 year: 2019 ident: 10.1016/j.ijcard.2022.09.062_bb0055 article-title: ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes? publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.119.013296 – volume: 121 start-page: 228 year: 2012 ident: 10.1016/j.ijcard.2022.09.062_bb0200 article-title: Characteristics and outcome in acute coronary syndrome patients with and without established modifiable cardiovascular risk factors: insights from the Nationwide AMIS plus registry 1997–2010 publication-title: Cardiology. doi: 10.1159/000337324 – volume: 9 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0310 article-title: Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8,680 Asian patients publication-title: Front Cardiovasc Med. doi: 10.3389/fcvm.2022.869168 – volume: 34 start-page: 1040 year: 2019 ident: 10.1016/j.ijcard.2022.09.062_bb0205 article-title: Clinical characteristics and outcomes in acute myocardial infarction patients with versus without any cardiovascular risk factors publication-title: The Korean journal of internal medicine. doi: 10.3904/kjim.2018.056 – year: 2021 ident: 10.1016/j.ijcard.2022.09.062_bb0330 – volume: 3 start-page: 629 year: 2007 ident: 10.1016/j.ijcard.2022.09.062_bb0275 article-title: Ischemic preconditioning: protection against myocardial necrosis and apoptosis publication-title: Vasc. Health Risk Manag. – volume: 96 start-page: 611 year: 2005 ident: 10.1016/j.ijcard.2022.09.062_bb0240 article-title: Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality publication-title: Am. J. Cardiol. doi: 10.1016/j.amjcard.2005.04.029 – volume: 24 start-page: 274 year: 2017 ident: 10.1016/j.ijcard.2022.09.062_bb0010 article-title: Trends in long-term prognosis after acute coronary syndrome publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487316679522 – volume: 10 start-page: 476 year: 2019 ident: 10.1016/j.ijcard.2022.09.062_bb0080 article-title: Seriously misleading results using inverse of freeman-Tukey double arcsine transformation in meta-analysis of single proportions publication-title: Res. Synth. Methods doi: 10.1002/jrsm.1348 – volume: 47 start-page: 4 year: 1957 ident: 10.1016/j.ijcard.2022.09.062_bb0005 article-title: Coronary heart disease in the Framingham study publication-title: Am J Public Health Nations Health. doi: 10.2105/AJPH.47.4_Pt_2.4 – volume: 3 start-page: 692 year: 2005 ident: 10.1016/j.ijcard.2022.09.062_bb0065 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients publication-title: J. Thromb. Haemost. doi: 10.1111/j.1538-7836.2005.01204.x – volume: 47 year: 2022 ident: 10.1016/j.ijcard.2022.09.062_bb0165 article-title: Trends and outcomes of ST-segment-elevation MI in hospitalized patients without standard modifiable cardiovascular risk factors publication-title: Curr. Probl. Cardiol. doi: 10.1016/j.cpcardiol.2022.101271 – volume: 42 start-page: 563 year: 2012 ident: 10.1016/j.ijcard.2022.09.062_bb0190 article-title: Obesity and severe obesity forecasts through 2030 publication-title: Am. J. Prev. Med. doi: 10.1016/j.amepre.2011.10.026 – volume: 24 start-page: 1824 year: 2020 ident: 10.1016/j.ijcard.2022.09.062_bb0015 article-title: Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487317720287 – reference: 36306947 - Int J Cardiol. 2023 Jan 1;370:83 |
| SSID | ssj0004998 |
| Score | 2.586084 |
| SecondaryResourceType | review_article |
| Snippet | Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes, hyperlipidemia, hypertension, and smoking, are used for risk stratification in... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 432 |
| SubjectTerms | Acute Coronary Syndrome - epidemiology Acute Coronary Syndrome - mortality Angiotensins Atherosclerosis Diabetes Mellitus - therapy Heart Failure Humans Hypertension Mortality Risk factor Risk Factors Shock, Cardiogenic SMuRF ST Elevation Myocardial Infarction ST-segment elevation myocardial infarction |
| Title | Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0167527322014139 https://dx.doi.org/10.1016/j.ijcard.2022.09.062 https://www.ncbi.nlm.nih.gov/pubmed/36179904 https://www.proquest.com/docview/2720428465 |
| Volume | 371 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQlapeKkq_FlrkSj1iduPPpDeEQNtWcGhB4mZNvLYUBFnEJgcu_R39uXgSe6seEFWPiTxyknE8b-w3z4R89l6WtZMRuTmomDR8wcpKlcxjsNawgLLA4uTTMz2_kN8u1eUGOcq1MEirTHP_OKcPs3W6M01fc3rbNNOfSKBH-TDOkawosIhPSoNj_eDXH5pHRPRl1vfG1rl8buB4NVcu-iFmiZwPaqeaPxaeHoOfQxg62SIvE36kh-MjviIbvt0mz0_TDvlr8nskbtCbAVZHiE2bloLrO08dihXA3T3NKgU0iaquKK7GLvuO5oWFaL5oQoNlVRTJ5zQdy_OF_vCr_jpaYFkKBTrqidAb3wGDpG9Cl4EW-7xU-4bzdR9vyMXJ8fnRnKXTF5iLQb1jwftSi5orTOlECVK7YhZcCDEF8wizdKiKys2UMybiFuelMaECFLcJyohCvCWb7bL175E-FRZKAKaSlawF1JWSoDxoL6GuFUyIyB_duiRNjidkXNvMQbuyo6ssusrOKhtdNSFsbXU7SnM80V5lf9pcdhonShtjxxN2Zm3319D8B8tPedjY-NfiVgy0ftmvLO5-x8RPajUh78bxtH4HoVGlbyZ3_rvfXfIiXiFPjhXqA9ns7nr_MWKnrt4bfo498uzw6_f52QPQaBlR |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4lmWp5E41uzGr8TcUEW1QLcHaKXeLMdrS6nabNVNDr30d_BzmUnsRRyqIq5JRnnMxPON_c1nQj6EIKvaS0Bu3hkmS75klVEVC5istVu6qsDm5MWhnh_LbyfqZIvs5V4YpFWmsX8c04fROh2Zpq85vWia6U8k0KN8GOdIVhTmDrkrMaIgqD9e_-F5AKSvssA3Xp775waSV3PqwRFQJnI-yJ1qflN-ugl_Dnlo_xF5mAAk_Tw-42OyFdon5N4iLZE_Jb9G5gY9H3A1YGzatNT5vgvUo1qBu7yiWaaAJlXVNcXp2FXf0TyzAObLJjbYV0WRfU7Tvjyf6I-w7s_AAvtSqKOjoAg9D51jLgmc0FWkxS6v1G7J-eYez8jx_pejvTlL2y8wD1m9YzGESouaK6zpROWk9sUs-hihBguIs3Q0hfEz5csSgIsPsiyjcahuE1UpCvGcbLerNrxA_lRcKuGwljSyFq42SjoVnA7S1bVyEyLyR7c-aZPjFhlnNpPQTu3oKouusjNjwVUTwjZWF6M2xy3Xq-xPm_tOYaS0kDxusSs3dn_F5j9Yvs9hY-G3xbUY14ZVv7a4_A2Vn9RqQnbGeNq8g9Ao0zeTL__7vu_I_fnR4sAefD38_oo8gDNImmOFek22u8s-vAEg1dVvhx_lNxgwGuI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Higher+mortality+in+acute+coronary+syndrome+patients+without+standard+modifiable+risk+factors%3A+Results+from+a+global+meta-analysis+of+1%2C285%2C722+patients&rft.jtitle=International+journal+of+cardiology&rft.au=Kong%2C+Gwyneth&rft.au=Chin%2C+Yip+Han&rft.au=Chong%2C+Bryan&rft.au=Goh%2C+Rachel+Sze+Jen&rft.date=2023-01-15&rft.pub=Elsevier+B.V&rft.issn=0167-5273&rft.volume=371&rft.spage=432&rft.epage=440&rft_id=info:doi/10.1016%2Fj.ijcard.2022.09.062&rft.externalDocID=S0167527322014139 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-5273&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-5273&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-5273&client=summon |